Oncology and biomedicine terminology · MLC-0111

Oncology and biomedicine terms: A (3,095)

Page 3 of 7

• AnktivaA drug used with bacillus Calmette-Guérin (BCG) to treat adults with bladder cancer that has not invaded the...
• ANLLA fast-growing cancer in which too many myeloblasts (a type of immature white blood cell) are found in the...
• AnnamycinA substance that is being studied in the treatment of cancer. It belongs to the family of drugs called...
• Annamycin liposomalA liposome-encapsulated form of the semi-synthetic doxorubicin analogue annamycin with antineoplastic...
• Annonaceous acetogeninsA family of naturally occurring polyketides that consist of C32 or C34 long chain fatty acids and combined...
• AnorexiaAn abnormal loss of the appetite for food. Anorexia can be caused by cancer, AIDS, a mental disorder (i.e...
• Anorexia nervosaAn eating disorder marked by an intense fear of gaining weight, a refusal to maintain a healthy weight, and a...
• AnoscopyA procedure in which a short, lighted tube called an anoscope is inserted into the anus and lower part of the...
• AnpocoginAn 85-amino acid recombinant peptide derived from protein c2 of the hemophagocytic hookworm Ancylostoma...
• ANSThe part of the nervous system that controls muscles of internal organs (such as the heart, blood vessels...
• AnsamycinAn anticancer drug that belongs to the family of drugs called antineoplastic antibiotics.
• AnselamimabA chimeric monoclonal antibody specifically targeting human immunoglobulin light chain (LC)-related fibrils...
• AntagonistIn medicine, a substance that stops the action or effect of another substance. For example, a drug that...
• AntenatalHaving to do with the time a female is pregnant, before birth occurs. Also called prenatal.
• AnteriorIn human anatomy, has to do with the front of a structure, or a structure found toward the front of the body.
• Anterior mediastinotomyA procedure in which a tube is inserted into the chest to view the tissues and organs in the area between the...
• Anterior mediastinumThe area in the front part of the chest between the lungs. Also called prevascular space.
• Anterior pelvic exenterationSurgery to remove the urethra, lower part of the ureters, uterus, cervix, vagina, and bladder.
• Anterior urethral cancerA disease in which malignant (cancer) cells are found in the part of the urethra (the tube through which...
• Anthocyanin-rich corn extractA corn-based, water-soluble extract rich in the polyphenol anthocyanin, with potential antioxidant...
• AnthracenedioneAn anticancer drug that belongs to the family of drugs called anticancer antibiotics.
• AnthracyclineA type of antibiotic that comes from certain types of Streptomyces bacteria. Anthracyclines are used to treat...
• AnthraquinoneA type of anticancer drug.
• Anti c-KIT antibody-drug conjugate LOP628An antibody-drug conjugate (ADC) consisting of a humanized monoclonal antibody against the stem cell factor...
• Anti LAG-3 monoclonal antibody HLX26A recombinant monoclonal antibody targeting the co-inhibitory receptor lymphocyte-activation gene 3 protein...
• Anti PD1/IL-15 fusion protein SAR445877A fusion protein composed of an antibody moiety targeting the negative immunoregulatory human cell receptor...
• anti-4-1BB Fab/TriCD40L fusion protein IMB071703A bi-functional fusion protein consisting of a monovalent Fab fragment directed against 4-1BB (CD137; tumor...
• anti-4-1BB/5T4 bispecific Aantibody ALG.APV-527A human bispecific antibody composed of a single-chain variable fragment (scFv) domain targeting the immune...
• anti-4-1BB/anti-EGFR bispecific antibody HLX35A recombinant human bispecific antibody targeting both the tumor-associated antigen (TAA) epidermal growth...
• anti-4-1BB/PD-L1 bispecific antibody BH3120A heterodimeric immunoglobulin (IgG)-like bispecific antibody, with biased binding affinities, targeting...
• anti-5T4 antibody-drug conjugate ASN004An antibody-drug conjugate (ADC) composed of an antibody directed against 5T4 and conjugated, via a...
• anti-5T4 antibody-drug conjugate PF-06263507An antibody-drug conjugate composed of an antibody directed against 5T4 and conjugated, via the stable linker...
• anti-5T4 antibody-drug conjugate SYD1875An antibody-drug conjugate (ADC) composed of a humanized immunoglobulin G1 (IgG1) monoclonal antibody...
• anti-5T4 CAR-NK cellsA preparation of allogeneic natural killer cells (NKs) expressing a chimeric antigen receptor (CAR) specific...
• anti-5T4/D-2102 antibody-drug conjugate ACR246An antibody-drug conjugate (ADC) composed of a humanized monoclonal antibody directed against the oncofetal...
• anti-5T4/exatecan antibody-drug conjugate TUB-030An antibody-drug conjugate (ADC) composed of a Fc-silenced, humanized, immunoglobulin G1 (IgG1) monoclonal...
• anti-5T4/MMAE antibody-drug conjugate XB010An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against the oncofetal antigen 5T4...
• anti-A33 monoclonal antibody KRN330A recombinant fully human monoclonal antibody directed against the human A33 antigen, with potential...
• anti-A5B1 integrin monoclonal antibody PF-04605412A monoclonal antibody directed against the human alpha5beta1 integrin with potential antiangiogenic and...
• anti-ACTR/4-1BB/CD3zeta-viral vector-transduced autologous T lymphocytes ACTR087Autologous T lymphocytes that are genetically modified and transfected with a viral vector expressing the...
• anti-ADAM9 ADC IMGC936An immunoconjugate consisting of a humanized monoclonal antibody directed against the tumor-associated...
• anti-AG7 antibody drug conjugate AbGn-107An antibody drug conjugate (ADC) composed of a monoclonal antibody that targets the tumor-associated antigen...
• anti-AGS-16 monoclonal antibody AGS-16M18A humanized monoclonal antibody directed against the activator of g-proteins signaling (AGS) cell surface...
• anti-AGS-5 antibody-drug conjugate ASG-5MEAn antibody drug conjugate (ADC) containing the fully human IgG2k monoclonal antibody targeting an epitope of...
• anti-AGS-8 monoclonal antibody AGS-8M4A humanized monoclonal antibody directed against the activator of g-proteins signaling (AGS) cell surface...
• anti-ALK-1 monoclonal antibody GT90001A human immunoglobulin G2 (IgG2) monoclonal antibody against activin receptor-like kinase-1 (ALK-1; ALK1)...
• anti-ALPP/ALPPL2/MMAE ADC SGN-ALPVAn antibody-drug conjugate (ADC) composed of h12F3, a humanized immunoglobulin G1 (IgG1) monoclonal antibody...
• anti-AMHR2 monoclonal antibody GM102An engineered, humanized, low fucose monoclonal antibody against mullerian hormone receptor II (Müllerian...
• AntiandrogenA substance that keeps androgens (male sex hormones) from binding to proteins called androgen receptors...
• Anti-androgen siRNA SXL01A small-interfering RNA (siRNA) directed against androgen receptor (AR), with potential antineoplastic...
• Antiandrogen therapyTreatment with drugs to block the action of androgens (male hormones) in the body. Androgens, such as...
• anti-ANG2 monoclonal antibody MEDI-3617A fully human IgG1 monoclonal antibody against angiopoietin 2 (ANG2), with potential antiangiogenic activity...
• AntiangiogenesisPrevention of the growth of new blood vessels.
• Antiangiogenesis agentA drug or substance that keeps new blood vessels from forming. In cancer treatment, antiangiogenesis agents...
• AntiangiogenicHaving to do with reducing the growth of new blood vessels.
• Antiangiogenic drug combination TL-118A proprietary, oral suspension containing a combination of agents comprised of a nonsteroidal...
• Anti-angiopoietin monoclonal antibody AMG 780An immunoglobulin (Ig) G2 monoclonal antibody targeting the proangiogenic cytokines angiopoietin 1 (Ang1) and...
• Antianxiety agentA drug used to treat symptoms of anxiety, such as feelings of fear, dread, uneasiness, and muscle tightness...
• AntiapoptoticSomething that prevents apoptosis. Apoptosis is a type of cell death in which a series of molecular steps in...
• anti-APRIL monoclonal antibody BION-1301A humanized monoclonal antibody targeting a proliferation-inducing ligand (APRIL; tumor necrosis factor...
• anti-ASCT2 antibody-drug conjugate MEDI7247An antibody-drug conjugate (ADC) consisting of a human monoclonal antibody against neutral amino acid...
• anti-AXL monoclonal antibody-MMAE conjugateAn antibody-drug conjugate (ADC), consisting of a human monoclonal antibody directed against AXL receptor...
• anti-B4 blocked ricin immunotoxinAn immunotoxin comprised of an anti-B4 (anti-CD19) murine monoclonal antibody linked to the modified...
• anti-B7-H3 antibody DS-5573aAn antibody directed against the immunoregulatory protein B7-homologue 3 (B7-H3, CD276), with potential...
• anti-B7-H3 antibody-drug conjugate BAT8009An antibody-drug conjugate (ADC) composed of a humanized monoclonal antibody directed against the...
• anti-B7-H3 antibody-drug conjugate DB-1311An antibody-drug conjugate (ADC) composed of a humanized monoclonal antibody directed against the...
• anti-B7-H3 antibody-drug conjugate HS-20093An antibody-drug conjugate (ADC) composed of a humanized immunoglobulin (Ig) G1 monoclonal antibody directed...
• anti-B7-H3 antibody-drug conjugate MGC026An antibody-drug conjugate (ADC) composed of vobramitamab, a humanized monoclonal antibody directed against...
• anti-B7-H3 antibody-drug conjugate MHB088CAn antibody-drug conjugate (ADC) composed of a humanized monoclonal antibody directed against the...
• anti-B7-H3 antibody-drug conjugate YL201An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against the immunoregulatory...
• anti-B7-H3 CAR T cellsA preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor...
• anti-B7-H3 CAR T cells TAA06A preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor...
• anti-B7-H3/anti-EGFR bispecific antibody-drug conjugate IBI3001An antibody-drug conjugate (ADC) composed of a bispecific antibody directed against the tumor associated...
• anti-B7-H3/CD28 bispecific antibody XmAb808A bispecific antibody directed against the tumor-associated antigen (TAA) and immunoregulatory protein...
• anti-B7-H3/topoisomerase-1 inhibitor antibody-drug conjugate BGB-C354An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against the immunoregulatory...
• anti-B7-H4 antibody drug conjugate BG-C9074An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against the T-cell checkpoint...
• anti-B7-H4 antibody-drug conjugate XMT-1660An antibody-drug conjugate (ADC) composed of XMT-1604, a human immunoglobulin G1 (IgG1) monoclonal antibody...
• anti-B7-H4 monoclonal antibodyAny monoclonal antibody directed against the T-cell checkpoint ligand B7-H4 (B7H4; V-set domain-containing...
• anti-B7-H4 monoclonal antibody NC762A humanized immunoglobulin G1 kappa (IgG1k) monoclonal antibody targeting B7-H4 (V-set domain-containing...
• Anti-B7-H4/ TOP1i Antibody-drug Conjugate AZD8205An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against B7-H4 (V-set...
• anti-B7-H4/anti-4-1BB bispecific antibody ABL103A T-cell engaging (TCE) bispecific antibody against both the tumor-associated antigen (TAA) B7-H4 (V-set...
• anti-B7-H4/anti-4-1BB bispecific antibody CLN-418An Fc-silenced bispecific antibody against both the tumor-associated antigen (TAA) B7-H4 (V-set...
• anti-B7-H4/anti-CD3 bispecific antibody GEN1047A bispecific monoclonal antibody against both B7-H4 (V-set domain-containing T-cell activation inhibitor 1...
• anti-B7-H4/anti-CD3 bispecific antibody PF-07260437A bispecific monoclonal antibody against both B7-H4 (V-set domain-containing T-cell activation inhibitor 1...
• anti-B7-H4/MMAE ADC LNCB74An antibody-drug conjugate (ADC) composed of a human immunoglobulin (Ig) G1 kappa monoclonal antibody...
• anti-B7-H4/TOP1i antibody-drug conjugate GSK5733584An antibody-drug conjugate (ADC) composed of a humanized immunoglobulin G1 (IgG1) monoclonal antibody...
• anti-B7-H6/Anti-CD3 bispecific antibody BI 765049An immunoglobulin G (IgG)-like bispecific T-cell engaging antibody directed against both natural cytotoxicity...
• anti-B7-H6/anti-CD3 bispecific antibody TGI-6A bispecific antibody directed against both natural cytotoxicity triggering receptor 3 ligand 1 (NCR3LG1...
• anti-B7H7 monoclonal antibody HBM1020A recombinant human monoclonal antibody directed against HERV-H LTR-associating protein 2 (HHLA2; B7 homolog...
• AntibacterialA substance that kills bacteria or stops them from growing and causing disease.
• anti-BAFFR monoclonal antibody ESG206A monoclonal antibody that is directed against the tumor-associated antigen (TAA) B-cell activating factor...
• anti-BCMA antibody SEA-BCMAA humanized, afucosylated monoclonal antibody created using the proprietary, sugar-engineered antibody (SEA)...
• anti-BCMA antibody-drug conjugate AMG 224An antibody-drug conjugate (ADC) comprised of an anti-human B-cell maturation antigen (BCMA) immunoglobulin...
• anti-BCMA antibody-drug conjugate CC-99712An antibody-drug conjugate (ADC) consisting of a monoclonal antibody against the tumor-associated antigen...
• anti-BCMA CAR-NK cellsA preparation of umbilical cord blood (CB)-derived natural killer cells (NKs) expressing a chimeric antigen...
• anti-BCMA SparX protein plus BCMA-directed anti-TAAG ARC T cells CART-ddBCMAAn immunotherapeutic combination agent composed of antigen receptor complex T cells (ARC-T cells) which...
• anti-BCMA/alpha-amanitin antibody-drug conjugate HDP-101An antibody-drug conjugate (ADC) consisting of a monoclonal antibody against the tumor-associated antigen...
• anti-BCMA/anti-CD3 bispecific antibody EMB-06A tetravalent, bispecific antibody directed against both the tumor-associated antigen (TAA) human B-cell...
• anti-BCMA/anti-CD3 bispecific antibody REGN5459A human bispecific antibody directed against the tumor-associated antigen (TAA) human B-cell maturation...
• anti-BCMA/anti-CD3 bispecific antibody WVT078A bispecific antibody directed against both the tumor-associated antigen (TAA) human B-cell maturation...
• anti-BCMA/anti-CD3 T-cell engaging bispecific antibody ABBV-383A T-cell engaging, human, bispecific, immunoglobulin G4 (IgG4) monoclonal antibody (T-BsAb) directed against...
• anti-BCMA/anti-GPRC5D CAR T cells OriC321A preparation of T lymphocytes engineered to express chimeric antigen receptor(s) (CAR) targeting the human...
• anti-BCMA/anti-GPRC5D CAR-T cells BMS-986453A preparation of T lymphocytes engineered to express chimeric antigen receptor(s) (CAR) targeting the human...
• anti-BCMA/CD38/CD3 trispecific antibody ISB 2001A T-cell engager and trispecific antibody targeting the two tumor-associated antigens (TAAs) CD38 and human...
• anti-BCMA/GPRC5D/CD3 trispecific antibody JNJ-79635322A T-cell engager and trispecific antibody targeting the two tumor-associated antigens (TAAs) human B-cell...
• anti-BCMA/GPRC5D/CD3 trispecific antibody MBS314A T-cell engager and trispecific antibody targeting the two tumor-associated antigens (TAAs) human B-cell...
• anti-BCMA/GPRC5D/CD3 trispecific antibody SIM0500A humanized T-cell engager and trispecific antibody targeting the two tumor-associated antigens (TAAs) human...
• anti-BCMA/PBD ADC MEDI2228An antibody-drug conjugate (ADC) consisting of a fully human monoclonal antibody against the tumor-associated...
• AntibioticA drug used to treat infections caused by bacteria and other microorganisms.
• Antibiotic SQ109An orally available, acid-stable diamine antibiotic, with potential antimicrobial activity against a variety...
• AntibodyA protein made by plasma cells (a type of white blood cell) in response to an antigen (a substance that...
• Antibody receptor-Trap fusion protein IMM2520An immunoglobulin G1 (IgG1) Fc-containing bispecific antibody-receptor fusion protein targeting both the...
• Antibody ROSE12An antibody directed against an as of yet undisclosed antigen, with potential antineoplastic activity. Upon...
• Antibody STING drug conjugate TAK-500An antibody-drug conjugate (ADC) composed of an as of yet undisclosed antibody conjugated to TAK-676, an...
• Antibody therapyTreatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are...
• Antibody-dependent cell-mediated cytotoxicityA type of immune reaction in which a target cell or microbe is coated with antibodies and killed by certain...
• Antibody-dependent cellular cytotoxicityA type of immune reaction in which a target cell or microbe is coated with antibodies and killed by certain...
• Antibody-drug conjugateA substance made up of a monoclonal antibody chemically linked to a drug. The monoclonal antibody binds to...
• Antibody-drug conjugate ABBV-176An antibody-drug conjugate (ADC) composed of a proprietary monoclonal antibody against the prolactin receptor...
• Antibody-drug conjugate anti-TIM-1-vcMMAE CDX-014A monoclonal antibody-drug conjugate (ADC) comprised of human immunoglobulin G1 (IgG1) clone CR014, which...
• Antibody-drug conjugate PHN-010An antibody-drug conjugate (ADC) composed of an as of yet undisclosed monoclonal antibody directed against a...
• Antibody-drug conjugate RC118An antibody-drug conjugate (ADC) composed of an as of yet undisclosed monoclonal antibody against a...
• Antibody-drug conjugate SC-003An antibody-drug conjugate (ADC) composed of a proprietary monoclonal antibody against a tumor-associated...
• Antibody-drug conjugate SC-005An antibody-drug conjugate (ADC) composed of a proprietary monoclonal antibody against a tumor-associated...
• Antibody-drug conjugate SC-007An antibody-drug conjugate (ADC) composed of a monoclonal antibody against an undisclosed tumor-associated...
• antibody/PNE-based biologic agent ABBV-461A biologic agent composed of an antibody fragment targeting an as of yet unidentified tumor-associated...
• anti-BTLA monoclonal antibody HFB200603A monoclonal antibody directed against B- and T-lymphocyte attenuator (BTLA), with potential immune...
• anti-BTN1A1 monoclonal antibody hSTC810A humanized monoclonal antibody directed against the immune checkpoint protein butyrophilin 1A1 (BTN1A1)...
• anti-BTN3A agonistic monoclonal antibody ICT01A humanized agonistic monoclonal antibody directed against butyrophilin subfamily 3 member A (BTN3A; CD277)...
• anti-C4.4a antibody-drug conjugate BAY1129980An antibody-drug conjugate (ADC) composed of an antibody against a structural homolog of the urokinase-type...
• anti-C5aR1 monoclonal antibody TJ210A differentiated human monoclonal antibody targeting the complement component fragment 5a receptor (C5aR1...
• anti-CA19-9 monoclonal antibody BNT321A human immunoglobulin G1 (IgG1) monoclonal antibody directed against the carbohydrate antigen sialyl Lewis A...
• anti-CA6-DM4 immunoconjugate SAR566658An immunoconjugate consisting of a humanized monoclonal antibody against the tumor-associated sialoglycotope...
• AnticachexiaDescribes a drug or effect that works against cachexia (loss of body weight and muscle mass).
• Anticachexia agent MT-102A small molecule with potential anticachexia activity. The anticachexia agent MT-102 may increase protein...
• Anticachexia agent OC514A combination agent composed of two active ingredients, with potential anti-cachexia and anti-sarcopenia...
• anti-CAIX antibody-drug conjugate BAY79-4620An antibody-drug conjugate (ADC) composed of 3ee9, a monoclonal antibody directed against the...
• anti-CAIX CAR T cellsA preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor...
• anti-CALRmut/anti-CD3 bispecific antibody JNJ-88549968A bispecific antibody directed against both the mutated form of calreticulin (CALRmut; mutCALR) and the...
• Anticancer antibioticA type of anticancer drug that blocks cell growth by interfering with DNA, the genetic material in cells...
• Anticancer therapyTreatment to stop or prevent cancer. Types of anticancer therapy include chemotherapy, radiation therapy...
• anti-Caprin-1 monoclonal antibody TRK-950A humanized monoclonal antibody directed against cell cycle associated protein 1 (cytoplasmic activation- and...
• AnticarcinogenicHaving to do with preventing or delaying the development of cancer.
• anti-CCR2 monoclonal antibody MLN1202A substance being studied as a treatment for atherosclerosis (a build-up of fat in the arteries). It is also...
• anti-CCR7 antibody-drug conjugate JBH492An antibody-drug conjugate (ADC) composed of an antibody targeting CC chemokine receptor 7 (CCR7) and...
• anti-CCR7 monoclonal antibody CAP-100A humanized immunoglobulin G1 (IgG1) monoclonal antibody against C-C-chemokine receptor 7 (CCR7), with...
• anti-CCR8 monoclonal antibody ABBV-514An afucosylated monoclonal antibody directed against human C-C motif chemokine receptor 8 (CCR8), with...
• anti-CCR8 monoclonal antibody AMG 355A monoclonal antibody directed against C-C-chemokine receptor 8 (CCR8), with potential immunomodulating and...
• anti-CCR8 monoclonal antibody BAY3375968A human immunoglobulin G1 (IgG1) afucosylated monoclonal antibody against C-C-chemokine receptor 8 (CCR8)...
• anti-CCR8 monoclonal antibody BGB-A3055A monoclonal antibody directed against C-C-chemokine receptor 8 (CCR8), with potential immunomodulating and...
• anti-CCR8 monoclonal antibody BMS-986340A human immunoglobulin G1 (IgG1) nonfucosylated (NF) monoclonal antibody against C-C-chemokine receptor 8...
• anti-CCR8 monoclonal antibody CM369A monoclonal antibody against C-C-chemokine receptor 8 (CCR8), with potential immunomodulating and...
• anti-CCR8 monoclonal antibody GS-1811A humanized immunoglobulin G1 (IgG1) afucosylated monoclonal antibody against C-C-chemokine receptor 8...
• anti-CCR8 monoclonal antibody HC006A monoclonal antibody directed against human C-C motif chemokine receptor 8 (CCR8), with potential...
• anti-CCR8 monoclonal antibody RO7502175A humanized immunoglobulin G1 (IgG1) afucosylated monoclonal antibody directed against C-C-chemokine receptor...
• anti-CCR8 monoclonal antibody S-531011A human immunoglobulin G1 (IgG1) monoclonal antibody against C-C-chemokine receptor 8 (CCR8), with potential...
• anti-CCR8 monoclonal antibody ZL-1218A humanized immunoglobulin G1 (IgG1) monoclonal antibody against C-C-chemokine receptor 8 (CCR8), with...
• anti-CD117/amanitin antibody-drug conjugate MGTA-117An antibody-drug conjugate (ADC) consisting of a human monoclonal antibody directed against CD117...
• anti-CD11b monoclonal antibody ASD141A monoclonal antibody directed against the CD11b (integrin alpha-M; ITGAM; integrin alpha M chain) subunit of...
• anti-CD122 humanized monoclonal antibody Mik-beta-1A humanized version of the immunoglobulin (Ig) G1 monoclonal antibody Mik-Beta-1 (Hu-Mik-Beta-1) directed...
• anti-CD123 ADC IMGN632An antibody-drug conjugate (ADC) consisting of a humanized anti-CD123 (interleukin-3 (IL-3) receptor alpha...
• anti-CD123 monoclonal antibody CSL360A chimeric IgG1 monoclonal antibody against CD123 (Interleukin-3 receptor alpha chain) with potential...
• anti-CD123 monoclonal antibody KHK2823A fully human monoclonal antibody against CD123 (interleukin-3 receptor alpha chain) with potential...
• anti-CD123 x anti-CD3 bispecific antibody XmAb14045An anti-CD123/anti-CD3 bispecific monoclonal antibody, in which most of the naturally-occurring Fc domain is...
• anti-CD123/anti-CD16A bispecific antibody AFM28A human, tetravalent, bispecific immunoglobulin G1 (IgG1)-single chain variable fragment (scFv) fusion...
• anti-CD123/anti-CD3 bispecific DART molecule MGD024An Fc-bearing, bispecific antibody-like protein directed against the tumor-associated antigen (TAA) CD123 and...
• anti-CD123/CD3 bispecific antibody APVO436An immunoglobulin Fc-modified bispecific monoclonal antibody against the tumor-associated antigen (TAA) CD123...
• anti-CD123/CD3 bispecific antibody JNJ-63709178A humanized anti-CD123/anti-CD3 bispecific monoclonal antibody, with potential immunostimulating and...
• anti-CD123/CD3 BiTE antibody SAR440234A bispecific T-cell engager (BiTE) antibody comprised of a humanized Fc-silenced immunoglobulin G1 (IgG1)...
• anti-CD123/duocarmazine ADC BYON4413An antibody-drug conjugate (ADC) consisting of a humanized, immunoglobulin G1 (IgG1) monoclonal antibody...
• anti-CD123/kinesin spindle protein inhibitor antibody-drug conjugate VIP943An antibody-drug conjugate (ADC) consisting of a monoclonal antibody against the interleukin-3 (IL3)-receptor...
• anti-CD123-pyrrolobenzodiazepine dimer antibody drug conjugate SGN-CD123AAn antibody-drug conjugate (ADC) consisting of an anti-CD123 humanized monoclonal antibody conjugated, via a...
• anti-CD123/TOP1i antibody-drug conjugate AZD9829An antibody-drug conjugate (ADC) consisting of a monoclonal antibody against the interleukin-3 (IL3)-receptor...
• anti-CD133-CAR vector-transduced allogeneic T lymphocytesA preparation of allogeneic peripheral blood T lymphocytes (PBTL) that have been genetically modified to...
• anti-CD133-PE38-KDEL fusion proteinA fusion protein consisting of an anti-single-chain variable fragment (scFv) peptide sequence targeting the...
• anti-CD137 agonistic monoclonal antibody ADG106A human agonistic monoclonal antibody targeting CD137 (4-1BB; tumor necrosis factor receptor superfamily...
• anti-CD137 agonistic monoclonal antibody ADG206An Fc-enhanced immunoglobulin G1 (IgG1) monoclonal antibody directed against the costimulatory receptor CD137...
• anti-CD137 agonistic monoclonal antibody AGEN2373A conditionally-active, fully human immunoglobulin G1 (IgG1) agonistic monoclonal antibody targeting the...
• anti-CD137 agonistic monoclonal antibody ATOR-1017A humanized agonistic immunoglobulin G4 (IgG4) monoclonal antibody targeting the costimulatory receptor CD137...
• anti-CD137 agonistic monoclonal antibody CTX-471A fully human immunoglobulin G4 (IgG4) agonistic monoclonal antibody targeting CD137 (4-1BB; tumor necrosis...
• anti-CD137 agonistic monoclonal antibody EU101A humanized agonistic monoclonal antibody targeting the costimulatory receptor CD137 (4-1BB; tumor necrosis...
• anti-CD137 agonistic monoclonal antibody YH004A humanized immunoglobulin G1 (IgG1) agonistic monoclonal antibody targeting the costimulatory receptor CD137...
• anti-CD137 monoclonal antibody PE0116A human immunoglobulin G4 (IgG4) agonistic monoclonal antibody directed against the inducible T-cell...
• anti-CD137/anti-FAP bispecific antibody BI 765179A bispecific antibody targeting both CD137 (4-1BB; tumor necrosis factor receptor superfamily member 9...
• anti-CD137/PD-L1 bispecific antibody AP203A bispecific antibody targeting both the human programmed death-ligand 1 (PD-L1) and CD137 (4-1BB; tumor...
• anti-CD137/PD-L1 bispecific monoclonal antibody FS222A tetravalent immunoglobulin G1 (IgG1) bispecific antibody targeting both the human programmed death-ligand 1...
• anti-CD138 antibody-IFNalpha fusion protein QXL138AMA masked immunocytokine (MIC) comprised of an immunoglobulin G1 (IgG1) antibody against the tumor-associated...
• Anti-CD147 monoclonal antibody DS-1471A monoclonal antibody directed against the tumor-associated antigen (TAA) CD147 (Basigin; EMMPRIN...
• anti-CD157 monoclonal antibody MEN1112A humanized, Fc-engineered, de-fucosylated monoclonal immunoglobulin G1 (IgG1) antibody directed against the...
• anti-CD161 monoclonal antibody IMT-009An Fc-attenuated human immunoglobulin G1 (IgG1) monoclonal antibody directed against the C-type lectin-like...
• anti-CD163 monoclonal antibody OR2805A human immunoglobulin G1 (IgG1) monoclonal antibody directed against the immunosuppressive receptor CD163...
• anti-CD166 probody-drug conjugate CX-2009A probody drug conjugate (PDC) composed of a recombinant antibody targeting the tumor-associated antigen...
• anti-CD16/IL-15/anti-CD33 trispecific natural Killer cell engager GTB-3650A trispecific natural killer (NK) cell engager comprised of an anti-cluster of differentiation 16 (CD16...
• anti-CD19 antibody-drug conjugate IKS03An antibody-drug conjugate (ADC) composed of a human monoclonal antibody directed against the...
• anti-CD19 antibody-drug conjugate SGN-CD19BAn antibody-drug conjugate (ADC) consisting of an anti-CD19 humanized monoclonal antibody (hBU12ec) with...
• anti-CD19 antibody-T-cell receptor-expressing T cells ET019003A preparation of T lymphocytes that have been engineered by incorporating an as of yet undisclosed...
• anti-CD19 CAR T cells AT101A preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor...
• anti-CD19 CAR-IL-18-expressing autologous T lymphocytesA preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) specific...
• anti-CD19 CAR-T cells XLCART001A preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor...
• anti-CD19 cord blood-derived CAR-NK cellsA preparation of cord blood (CB)-derived natural killer (NK) cells that have been genetically modified and...
• anti-CD19 iCAR NK cellsA preparation of natural killer (NK) cells engineered to express an inhibitory chimeric antigen receptor...
• anti-CD19 immunotoxinA monoclonal antibody linked to a toxic substance. It is being studied in the treatment of some types of...
• anti-CD19 monoclonal antibody DI-B4A low-fucosylated, humanized, IgG1 isotype, monoclonal antibody directed against the B-cell-specific membrane...
• anti-CD19 monoclonal antibody MDX-1342A fully human anti-CD19 monoclonal antibody directed against the B-cell-specific membrane protein CD-19 with...
• anti-CD19/anti-CD20/anti-CD22 CAR T cells LCAR-AIOA preparation of human T lymphocytes that have been genetically modified and transduced with a lentiviral...
• anti-CD19/anti-CD22 bispecific immunotoxin DT2219ARLAn immunotoxin consisting of two scFv ligands recognizing human CD19 and CD22 linked to the first 389 amino...
• anti-CD19/anti-CD3/anti-CD2 trispecific antibody PIT565A trispecific T-cell engager and antibody targeting the tumor-associated antigen (TAA) CD19, the T-cell...
• anti-CD19/anti-CD3/anti-CD28 trispecific antibody CC312A trispecific T-cell engager and antibody targeting the tumor-associated antigen (TAA) CD19, the T-cell...
• anti-CD19/anti-CD70 4SCAR-expressing bispecific T cellsA preparation of T lymphocytes that are genetically engineered to express a fourth-generation chimeric...
• anti-CD19/anti-CD79b 4SCAR-expressing bispecific T cellsA preparation of T lymphocytes that are genetically engineered to express a fourth-generation chimeric...
• anti-CD19-CAR CMV-specific T lymphocytesA preparation of human cytomegalovirus (CMV)-specific T lymphocytes that have been engineered to express a...
• anti-CD19-CAR FMC63-28Z retroviral vector-transduced allogeneic T lymphocytesAllogeneic T-lymphocytes derived from peripheral blood mononuclear cells (PBMC) transduced with a retroviral...
• anti-CD19-CAR retroviral vector-transduced autologous T cellsA preparation of autologous peripheral blood T lymphocytes (PBTL) that have been genetically modified to...
• anti-CD19-CAR-CD28/CD20-CAR-4-1BB-expressing autologous T lymphocytes Hu1928-Hu20BBA preparation of autologous human T lymphocytes that have been genetically modified to express the CAR...
• anti-CD19-CAR-CD3zeta-4-1BB-expressing natural killer cellsAllogeneic natural killer (NK) cells transduced with an mRNA expressing a chimeric antigen receptor (CAR)...
• anti-CD19/CD20 bicistronic CAR T cellsA preparation of T lymphocytes that have been transduced with a bicistronic vector encoding two distinct...
• anti-CD19-CD20-CAR-CD3zeta-4-1BB-expressing autologous T lymphocytesAutologous T lymphocytes that have been transduced with a lentiviral vector to express a chimeric antigen...
• anti-CD19/CD20/CD22 CAR T cellsA preparation of human T lymphocytes engineered to express a chimeric antigen receptor (CAR) specific for the...
• anti-CD19/CD20/CD22/CD30 CAR-T cellsA preparation of human T lymphocytes engineered to express a chimeric antigen receptor (CAR) specific for the...
• anti-CD19/CD22 CAR NK cellsA preparation of natural killer (NK) cells engineered to express a chimeric antigen receptor (CAR) specific...
• anti-CD19/CD28 bispecific antibody RO7443904A bispecific antibody directed against both the tumor-associated antigen (TAA) CD19 and the co-stimulatory...
• anti-CD19-CD28-zeta modified CAR CD3+ T lymphocytes JCAR015Genetically modified CD3-positive-enriched autologous T lymphocytes transduced with a replication incompetent...
• anti-CD19/CD3 bispecific antibody CN201A bispecific antibody and a T-cell engager targeting both the tumor-associated antigen (TAA) CD19, and the...
• anti-CD19/CD3 bispecific antibody GNR-084A bispecific antibody and a T-cell engager targeting both the tumor-associated antigen (TAA) CD19, and the...
• anti-CD19/CD3 bispecific antibody TNB-486A human bispecific T-cell engager antibody composed of a fixed-light-chain (FLC) arm targeting the CD3...
• anti-CD19/CD3 BiTE antibody AMG 562A bispecific T-cell engager (BiTE) antibody composed of two single-chain variable fragments (scFv), one...
• anti-CD19/CD3 T-cell engaging bispecific antibody CLN-978A half-life extended T-cell engaging bispecific antibody comprised of a single chain variable fragment (scFv)...
• anti-CD19/CD3 tetravalent antibody AFM11An anti-CD19/anti-CD3 bispecific tetravalent antibody with potential immunostimulatory and antineoplastic...
• anti-CD19-glucosteroid receptor modulator ADC ABBV-31An antibody drug conjugate (ADC) composed of an afucosylated immunoglobulin G1 (IgG1) monoclonal antibody...
• anti-CD1d/Vdelta2 gamma delta T-cell-engaging bispecific antibody LAVA-051A humanized bispecific gamma delta T-cell engager (TCE) antibody directed against both CD1d and Vdelta2, with...
• anti-CD20 antibody-drug conjugate MRG001An antibody-drug conjugate (ADC) composed of a chimeric anti-CD20 monoclonal antibody conjugated via a valine...
• anti-CD20 antibody-drug conjugate TRS005An antibody-drug conjugate (ADC) composed of an anti-CD20 monoclonal antibody conjugated via a...
• anti-CD20 B9E9 scFv-streptavidin fusion proteinAn Escherichia coli periplasm-expressed tetrameric fusion protein composed of four single-chain variable...
• anti-CD20 bispecific antibody DR-0201A bispecific monoclonal antibody that targets the human tumor-associated antigen (TAA) CD20, with potential...
• anti-CD20 CAR T cells C-CAR066A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• anti-CD20 monoclonal antibody B001A recombinant humanized monoclonal antibody directed against human CD20 with potential antineoplastic...
• anti-CD20 monoclonal antibody BAT4306FA recombinant, glycosylation-modified monoclonal antibody directed against the human B-cell-specific cell...
• anti-CD20 monoclonal antibody MIL62A glyco-engineered recombinant humanized monoclonal antibody directed against the human B-cell-specific cell...
• anti-CD20 monoclonal antibody PRO131921A third-generation, humanized monoclonal antibody directed against human CD20 with potential antineoplastic...
• anti-CD20 monoclonal antibody SCT400A chimeric monoclonal antibody directed against human CD20, with potential antineoplastic activity. Anti-CD20...
• anti-CD20 monoclonal antibody TL011A monoclonal antibody directed against human CD20 with potential antineoplastic activity. Anti-CD20...
• anti-CD200R1 monoclonal antibody 23ME-00610A humanized monoclonal antibody directed against the immune checkpoint cell surface transmembrane...
• anti-CD205 antibody-drug conjugate OBT076An antibody-drug conjugate (ADC) comprised of an anti-CD205 (lymphocyte antigen 75; Ly75) humanized...
• anti-CD20/anti-CD22 CAR T cellsA preparation of human T lymphocytes engineered to express chimeric antigen receptors (CARs) specific for the...
• anti-CD20/anti-CD3 bispecific antibody CM355A bispecific antibody and novel T-cell engager1 (nTCE) targeting both the tumor-associated antigen (TAA) CD20...
• anti-CD20/anti-CD3 bispecific antibody MBS303A bispecific antibody and T-cell engager (TCE) targeting both the tumor-associated antigen (TAA) CD20 and the...
• anti-CD20/anti-CD3 bispecific IgM antibody IGM2323An engineered immunoglobulin M (IgM) bispecific antibody, with potential antineoplastic activity...
• anti-CD20/anti-CD3/anti-CD8 trispecific antibody AZD5492A trispecific immunoglobulin G (IgG)-like T-cell engaging (TCE) antibody targeting the tumor-associated...
• anti-CD20-CAR-CD3zeta-4-1BB-expressing autologous T lymphocytesA preparation of autologous blood T-lymphocytes that have been genetically modified to express a chimeric...
• anti-CD20/CD3 bispecific antibody JS203A recombinant bispecific antibody targeting both the tumor-associated antigen (TAA) CD20 and the T-cell...
• anti-CD20/CD37 monoclonal antibody combination PSB202A combination agent composed of two humanized monoclonal antibodies, PSB102, an Fc-enhanced immunoglobulin G1...
• anti-CD20-engineered toxin body MT-3724An engineered toxin body (ETB) composed of the single-chain variable fragment (ScFv) from an antibody...
• anti-CD22 ADC TRPH-222An antibody-drug conjugate (ADC) composed of an anti-CD22 humanized monoclonal antibody site-specifically...
• anti-CD22 CAR T cells preparationAny preparation of chimeric antigen receptor (CAR) expressing T lymphocytes that targets the tumor-associated...
• anti-CD22 CAR-expressing T lymphocytesA preparation of human T lymphocytes transduced with a recombinant viral vector encoding a chimeric T-cell...
• anti-CD22 immunotoxinA monoclonal antibody linked to a toxic substance. It is being studied in the treatment of some types of...
• anti-CD22 monoclonal antibody-MMAE conjugate DCDT2980SAn antibody-drug conjugate (ADC) composed of MCDT2219A , a humanized IgG1 anti-CD22 monoclonal antibody...
• Anti-CD22 scFv TCRz:41BB-CAR Lentiviral Vector-transduced Autologous T-lymphocytesAutologous human T-lymphocytes transduced with a recombinant lentiviral vector encoding a chimeric T-cell...
• anti-CD226 agonist antibody LY3435151An agonistic antibody targeting the human cell surface glycoprotein CD226 (DNAX accessory molecule-1...
• anti-CD228/4-1BB bispecific agent SGN-BB228A bispecific agent composed of a human immunoglobulin G4 (IgG4) monoclonal antibody targeting the cell...
• anti-CD228/MMAE antibody-drug conjugate SGN-CD228AAn antibody-drug conjugate (ADC) composed of a humanized antibody targeting the cell surface antigen cluster...
• anti-CD22/anti-CD28 bispecific antibody REGN5837A hinge-stabilized human immunoglobulin G4 (IgG4) bispecific antibody directed against both the...
• anti-CD22-CAR m971-BBz lentiviral vector-transduced autologous T lymphocytesAutologous human T-lymphocytes transduced with a recombinant lentiviral vector encoding a chimeric T-cell...
• anti-CD22-CAR m971-BBz lentiviral vector-transduced autologous T lymphocytes CRG-022Autologous human T lymphocytes transduced with a recombinant lentiviral vector encoding a chimeric T-cell...
• anti-CD22/CD3 bispecific antibody JNJ-75348780A human bispecific antibody, with potential antineoplastic activity. Anti-CD22/CD3 bispecific antibody...
• anti-CD24 monoclonal antibody ATG-031A humanized monoclonal antibody targeting the cell surface protein CD24, with potential immune checkpoint...
• anti-CD24 monoclonal antibody KH-801A Fc-engineered humanized immunoglobulin G1 (IgG1) monoclonal antibody targeting the cell surface protein...
• anti-CD24/anti-4-1BB bispecific monoclonal antibody IBD0333A bispecific monoclonal antibody targeting the cell surface antigen cluster of differentiation 24 (CD24) and...
• anti-CD25 antibody-drug conjugate PF-08046032An antibody-drug conjugate (ADC) composed of a detuned-affinity monoclonal antibody directed against CD25...
• anti-CD25 monoclonal antibody BA1106A human monoclonal antibody directed against CD25 (interleukin-2 receptor subunit alpha; IL-2R alpha...
• anti-CD25-IL-2 monoclonal antibody AU-007A human immunoglobulin (Ig) G1 monoclonal antibody directed against the CD25 subunit-interacting domain of...
• anti-CD26 monoclonal antibody YS110A humanized, immunoglobulin G1 (IgG1) monoclonal antibody directed against the extracellular domain of...
• anti-CD27 monoclonal antibodyAny monoclonal antibody directed against the CD27 antigen (tumor necrosis factor receptor superfamily member...
• anti-CD27L antibody-drug conjugate AMG 172An immunoconjugate consisting of a human IgG1 monoclonal antibody directed against CD27L conjugated, via a...
• anti-CD3 immunotoxin A-dmDT390-bisFv(UCHT1)A bivalent recombinant fusion protein immunotoxin derived from the anti-CD3 monoclonal antibody UCHT1 with...
• anti-CD3 x anti-CD20 bispecific antibody-armed activated T cellsAutologous activated T cells that have been coated with bispecific antibodies (BiAb), with potential...
• anti-CD30 antibody-drug conjugate SGN-35CAn antibody-drug conjugate (ADC) composed of brentuximab (cAC10), a chimeric immunoglobulin G1 (IgG1)...
• anti-CD30 antibody-drug conjugate SGN-35TAn antibody-drug conjugate (ADC) composed of brentuximab (cAC10), a chimeric immunoglobuin G1 (IgG1)...
• anti-CD30 monoclonal antibody MDX-1401A fully human, second-generation, nonfucosylated monoclonal antibody directed against the cell surface...
• anti-CD30 monoclonal antibody XmAb2513A humanized monoclonal antibody directed against the cell surface receptor CD30 with potential...
• anti-CD30/CD3 bispecific antibody GEN3017An Fc-silenced immunoglobulin G1 (IgG1) bispecific monoclonal antibody against the tumor-associated antigen...
• anti-CD30/DM1 antibody-drug conjugate F0002An antibody drug conjugate (ADC) consisting of a monoclonal antibody directed against the tumor necrosis...
• anti-CD32B monoclonal antibody BI-1206A fully human monoclonal antibody targeting the Fc gamma receptor IIB (FcgRIIB; CD32B) with potential...
• anti-CD32B monoclonal antibody BI-1607A human immunoglobulin G1 (IgG1) monoclonal antibody targeting Fc gamma receptor IIB (FcgRIIB; CD32B), with...
• anti-CD33 antibody-drug conjugate BL-M11D1An antibody-drug conjugate (ADC) composed of gemtuzumab, an immunoglobulin G4 (IgG4) monoclonal antibody...
• anti-CD33 antibody-drug conjugate IMGN779An antibody-drug conjugate (ADC) consisting of the humanized monoclonal antibody Z4681A conjugated, via a...
• anti-CD33 antigen/CD3 receptor bispecific monoclonal antibody AMV564An anti-CD33/anti-CD3 bispecific tetravalent antibody, with potential immunostimulatory and antineoplastic...
• anti-CD33 CAR T cellsA preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor...
• anti-CD33 GSPT1 degrader BMS-986497A targeted protein degrader (TPD) composed of OR000283, an antibody directed against the tumor-associated...
• anti-CD33 monoclonal antibody BI 836858An engineered, fully human, immunoglobulin (Ig) G1 anti-CD33 monoclonal antibody, with potential...
• anti-CD33 monoclonal antibody-DM4 conjugate AVE9633An immunoconjugate consisting of the humanized monoclonal antibody huMy9-6 conjugated to the cytotoxic...
• anti-CD33/BET degrader ADC ABBV-787An antibody-drug conjugate (ADC) consisting of a monoclonal antibody directed against the tumor-associated...
• anti-CD33/CD123/CD70 DARPin CD3 engager MP0533A multi-specific T-cell engaging designed ankyrin repeat proteins (DARPin) composed of a chain of six...
• anti-CD33/CD3 bispecific antibodyA bispecific antibody directed against both the T-cell surface antigen CD3 and the tumor-associated antigen...
• anti-CD33/CD3 bispecific antibody GEM 333A bispecific antibody possessing two antigen-recognition and binding sites, one for the CD3 complex, a group...
• anti-CD33/CD3 bispecific antibody JNJ-67571244A bispecific antibody possessing two antigen-recognition and binding sites, one for the CD3 complex, a group...
• anti-CD352 antibody-drug conjugate SGN-CD352AAn antibody-drug conjugate (ADC) consisting of an engineered cysteine humanized monoclonal antibody (EC-mAb)...
• anti-CD37 bispecific monoclonal antibody GEN3009An Fc-engineered, humanized, bispecific hexamer formation-enhanced immunoglobulin (Ig) G1 monoclonal antibody...
• anti-CD37 monoclonal antibody BI 836826An Fc-engineered, chimeric immunoglobulin (Ig) G1 monoclonal antibody against the tumor-associated antigen...
• anti-CD37-CAR-expressing T lymphocytesA preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor...
• anti-CD38 antibody-drug conjugate STI-6129An antibody-drug conjugate (ADC) composed of STI-5171, a fully human monoclonal antibody targeting human cell...
• anti-CD38 monoclonal antibodyA substance that binds to a protein called CD38, which is found on some types of blood cells and in high...
• anti-CD38 monoclonal antibody CID-103A human immunoglobulin G1 (IgG1) monoclonal antibody directed against the cell surface glycoprotein...
• anti-CD38 monoclonal antibody SAR442085A preparation of Fc-engineered monoclonal antibody that targets the cell surface glycoprotein CD-38 with...
• anti-CD38 monoclonal antibody SCTC21CA monoclonal antibody that targets the cell surface glycoprotein CD38, with potential antineoplastic...
• anti-CD38 monoclonal antibody SG301A human immunoglobulin G1 kappa (IgG1k) monoclonal antibody that targets the cell surface glycoprotein CD38...
• anti-CD38 monoclonal antibody TAK-079A human, non-agonistic immunoglobulin G1 (IgG1) monoclonal antibody directed against the cell surface...
• anti-CD38 monoclonal antibody TJ202/MOR202A fully human monoclonal antibody directed against the cell surface glycoprotein CD-38 with potential...
• anti-CD38 scFv/Anti-DOTA scFv fusion protein CD38-SADAA fusion protein composed of a single chain variable fragment (scFv) targeting the human cell surface...
• anti-CD38/anti-CD47 bispecific antibody ISB 1442A human bispecific antibody directed against the human cell surface glycoproteins CD38 and CD47, with...
• anti-CD38/BCMA CAR T lymphocytesA preparation of T lymphocytes that have been genetically modified to express a dual-targeted chimeric...
• anti-CD38-CAR-TCRz/4-1BB-expressing T lymphocytesA preparation of genetically modified T lymphocytes that have been transduced with a lentiviral vector...
• anti-CD38/CD28xCD3 tri-specific monoclonal antibody SAR442257A tri-specific T-cell engager and monoclonal antibody targeting CD38, a human cell surface glycoprotein and...
• anti-CD38/CD3 bispecific monoclonal antibody GBR 1342A humanized, bispecific monoclonal antibody (BsAb) against human CD3, a T-cell surface antigen, and the human...
• anti-CD38/CD3 bispecific monoclonal antibody XmAb18968A bispecific monoclonal antibody targeting CD3, a T-cell surface antigen, and CD38, a human cell surface...
• anti-CD39 antibody/TGF-beta RII ectodomain fusion protein ES014A fusion protein composed of a monoclonal antibody directed against the cell surface receptor CD39 (cluster...
• anti-CD39 monoclonal antibody AB598An immunoglobulin G1 (IgG1) Fc-silent human monoclonal antibody directed against the cell surface receptor...
• anti-CD39 monoclonal antibody IPH5201A monoclonal antibody directed against the cell surface receptor CD39 (cluster of differentiation 39...
• anti-CD39 monoclonal antibody JS019A recombinant, fully human monoclonal antibody directed against the cell surface receptor CD39 (cluster of...
• anti-CD39 monoclonal antibody PUR001A monoclonal antibody directed against the cell surface receptor CD39 (cluster of differentiation 39...
• anti-CD39 monoclonal antibody SRF617A fully human monoclonal antibody directed against the cell surface receptor CD39 (cluster of differentiation...
• anti-CD39 monoclonal antibody TTX-030A fully human monoclonal antibody directed against the cell surface receptor CD39 (cluster of differentiation...
• anti-CD3/anti-5T4 bispecific antibody GEN1044A recombinant immunoglobulin G1 (IgG1) bispecific antibody targeting both the human T-cell surface antigen...
• anti-CD3/anti-BCMA bispecific antibody TQB2934A T-cell engaging, human, bispecific, immunoglobulin G1 (IgG1) monoclonal antibody directed against the...
• anti-CD3/anti-CD20 trifunctional bispecific monoclonal antibody FBTA05A trifunctional bispecific monoclonal antibody with potential antineoplastic activity. FBTA05 contains two...
• anti-CD3/anti-Claudin 18.2 bispecific antibody IBI389A bispecific antibody directed against the tumor-associated antigen (TAA) Claudin18.2 (CLDN18.2; A2 isoform...
• Anti-CD3/Anti-EGFR-bispecific Monoclonal Antibody-armed Activated Autologous T-lymphocytesAutologous activated T-cells that have been coated with bispecific antibodies (BiAb) comprised of an anti-CD3...
• anti-CD3/anti-GUCY2C bispecific antibody PF-07062119A bispecific antibody against human CD3, a T-cell surface antigen, and human guanylate cyclase 2C (GUCY2C...
• anti-CD3/CD19/CD20 trispecific antibody 1A46A trispecific immunoglobulin G (IgG)-like T-cell engaging antibody targeting the two tumor-associated...
• anti-CD3/CD38 bispecific monoclonal antibody AMG 424A humanized, bispecific monoclonal antibody (BsAb) targeting CD3, a T-cell surface antigen, and CD38, a human...
• anti-CD3/CD38 bispecific monoclonal antibody IGM-2644An engineered bispecific, pentameric immunoglobulin M (IgM) monoclonal antibody directed against CD3, a...
• anti-CD3/CD7-ricin toxin A immunotoxinAn immunotoxin (IT) combination composed of two antibody-drug conjugates (ADCs), one containing a monoclonal...
• anti-CD3/humanized 3F8 bispecific antibody-activated T lymphocytesAutologous activated T cells that have been coated with bispecific antibodies (BiAb) comprised of anti-CD3...
• anti-CD3/MUC1 antibody-armed PD-1 inhibitor-induced cytokine-induced killer cellsA preparation of cytokine-induced killer cells (CIKs), which have been exposed, ex vivo, to a specific set of...
• anti-CD4 CAR T cellsA preparation of T lymphocytes that have been genetically modified and transduced with a lentiviral vector...
• anti-CD40 agonist monoclonal antibody ABBV-927An agonistic monoclonal antibody directed against the B-cell surface antigen CD40, with potential...
• anti-CD40 agonist monoclonal antibody CDX-1140A fully human immunoglobulin G2 (IgG2) agonistic monoclonal antibody targeting the B-cell surface antigen...
• anti-CD40 agonist monoclonal antibody MIL97A recombinant, humanized, agonistic monoclonal antibody targeting the B-cell surface antigen CD40, with...
• anti-CD40 agonistic monoclonal antibody LNF1901A humanized, agonistic monoclonal antibody targeting the B-cell surface antigen CD40, with potential...
• Anti-CD40 monoclonal antibody Chi Lob 7/4An IgG1 chimeric monoclonal antibody agonist of the cell surface receptor CD40 with potential...
• anti-CD40/anti-TAA bispecific monoclonal antibody ABBV-428A bispecific monoclonal antibody composed of a binding domain for an epitope found on the cell-surface...
• anti-CD40L Fc-fusion protein BMS-986004A dimeric fusion protein composed of the C-terminus of the domain antibody (dAb) BMS2h-572-633 targeting the...
• anti-CD44 monoclonal antibody RO5429083A recombinant, humanized monoclonal antibody targeting the cancer stem cell (CSC) antigen CD44, with...
• anti-CD44v9 antibody-drug conjugate AMT-116An antibody-drug conjugate (ADC) composed of a humanized immunoglobulin G1 (IgG1) monoclonal antibody...
• anti-CD45 BC8 monoclonal antibody-streptavidin conjugateAn immunoconjugate containing a monoclonal antibody directed against the CD45 antigen BC8, conjugated to...
• anti-CD45 monoclonal antibodyA substance being studied in the treatment of some types of leukemia and lymphoma. Anti-CD45 monoclonal...
• anti-CD45 monoclonal antibody AHN-12A high affinity IgG1 monoclonal antibody with potential immunotherapeutic activity. Anti-CD45 monoclonal...
• anti-CD46 antibody-drug conjugate FOR46An antibody-drug conjugate (ADC) composed of a human monoclonal antibody directed against the cluster of...
• anti-CD46 monoclonal antibody YS5A human immunoglobulin G1 (IgG1) monoclonal antibody directed against the cell surface antigen cluster of...
• anti-CD47 ADC SGN-CD47MAn antibody-drug conjugate (ADC) consisting of a monoclonal antibody directed against human cell surface...
• anti-CD47 monoclonal antibody AO-176A humanized immunoglobulin G2 (IgG2) monoclonal antibody targeting the human cell surface antigen CD47, with...
• anti-CD47 monoclonal antibody CC-90002A monoclonal antibody targeting the human cell surface antigen CD47, with potential phagocytosis-inducing and...
• anti-CD47 monoclonal antibody HMPL-A83A humanized immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47, with...
• anti-CD47 monoclonal antibody IBI188A human immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47 with potential...
• anti-CD47 monoclonal antibody IMC-002A human immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47, with potential...
• anti-CD47 monoclonal antibody MIL95A humanized monoclonal antibody targeting leukocyte surface antigen CD47, with potential immune checkpoint...
• anti-CD47 monoclonal antibody SHR-1603A monoclonal antibody targeting the human cell surface antigen CD47, with potential phagocytosis-inducing and...
• anti-CD47 monoclonal antibody SRF231A human monoclonal antibody targeting the human cell surface antigen CD47, with potential...
• anti-CD47 monoclonal antibody STI-6643A human monoclonal antibody targeting leukocyte surface antigen CD47, with potential immune checkpoint...
• anti-CD47 monoclonal antibody ZL-1201A humanized immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47, with...
• anti-CD47/anti-HER2 bispecific antibody D3L-001A bispecific antibody directed against both the human tyrosine kinase receptor epidermal growth factor...
• anti-CD47/anti-HER2 bispecific antibody IMM2902A bispecific antibody directed against both the human tyrosine kinase receptor epidermal growth factor...
• anti-CD47/anti-mesothelin bispecific antibody NI-1801An immunoglobulin G1 (IgG1) bispecific human antibody directed against the human tumor-associated antigen...
• anti-CD47/anti-PD-L1 bispecific antibody 6MW3211A humanized bispecific antibody targeting both the human cell surface antigen CD47 and the immunosuppressive...
• anti-CD47/anti-PD-L1 bispecific antibody IBI322A recombinant bispecific antibody targeting both the human cell surface antigen CD47 and the...
• anti-CD47/anti-PD-L1 bispecific antibody PF-07257876A bispecific antibody targeting both the human cell surface antigen CD47 and the immunosuppressive ligand...
• anti-CD47/CD19 bispecific monoclonal antibody TG-1801A bispecific monoclonal antibody composed of two single-chain variable fragments (scFv), one directed against...
• anti-CD47/CD20 bispecific antibody CC-96673A humanized immunoglobulin G1 (IgG1) affinity-tuned bispecific antibody directed against both the...
• anti-CD47/CD20 bispecific antibody IMM0306A bispecific antibody directed against both the B-cell-specific membrane protein and tumor-associated antigen...
• anti-CD48/MMAE antibody-drug conjugate SGN-CD48AAn antibody-drug conjugate (ADC) composed of an antibody targeting the cell surface antigen CD48 that is...
• anti-CD52 monoclonal antibody ALLO-647A monoclonal antibody directed against the cell surface glycoprotein CD52 (CAMPATH-1 antigen; Cambridge...
• anti-CD7 CAR T cellsA preparation of T lymphocytes that have been genetically engineered to express a chimeric antigen receptor...
• anti-CD7 CAR T cells BT-007A preparation of T lymphocytes that have been genetically engineered and transduced with a lentiviral vector...
• anti-CD7 CAR T cells SenL-T7A preparation of T lymphocytes that have been genetically engineered to express a chimeric antigen receptor...
• anti-CD7 CAR-T cells RD13-02A preparation of T lymphocytes that have been genetically engineered to express a chimeric antigen receptor...
• anti-CD7 immunotoxinA toxin linked to an anti-CD7 antibody.
• anti-CD70 antibody-drug conjugate MDX-1203An antibody-drug conjugate (ADC) containing a fully human monoclonal antibody, directed against the...
• anti-CD70 antibody-drug conjugate PRO1160An antibody-drug conjugate (ADC) consisting of a human monoclonal antibody directed against the...
• anti-CD70 antibody-drug conjugate SGN-CD70AAn antibody-drug conjugate (ADC) containing an engineered cysteine monoclonal antibody (EC-mAb), directed...
• anti-CD70 CAR-expressing T lymphocytesA preparation of human T lymphocytes transduced with a recombinant viral vector encoding a chimeric T-cell...
• anti-CD70 monoclonal antibody IMM40HAn immunoglobulin G1 (IgG1) monoclonal antibody directed against the human tumor-associated antigen (TAA)...
• anti-CD70 monoclonal antibody MDX-1411A glycoengineered, fully human IgG1 monoclonal antibody directed against the extracellular domain of the...
• anti-CD70 monoclonal antibody SEA-CD70A humanized, nonfucosylated monoclonal antibody directed against the human CD70 antigen, with potential...
• anti-CD71/vcMMAE probody-drug conjugate CX-2029A probody-drug conjugate (PDC) composed of a monoclonal antibody directed against the transferrin receptor 1...
• anti-CD73 monoclonal antibody BMS-986179A monoclonal antibody targeting the ectoenzyme 5'-ecto-nucleotidase (cluster of differentiation 73; CD73...
• anti-CD73 monoclonal antibody CPI-006A type II humanized immunoglobulin G1 (IgG1) monoclonal antibody targeting the ectoenzyme...
• anti-CD73 monoclonal antibody HB0045A compound preparation composed of two monoclonal antibodies, HB0038 and HB0039, targeting different epitopes...
• anti-CD73 monoclonal antibody HLX23A recombinant, humanized monoclonal antibody targeting the ectoenzyme 5'-ecto-nucleotidase (cluster of...
• anti-CD73 monoclonal antibody IBI325A monoclonal antibody targeting the ectoenzyme 5'-ecto-nucleotidase (cluster of differentiation 73; CD73...
• anti-CD73 monoclonal antibody INCA00186A humanized monoclonal antibody targeting the ectoenzyme 5'-ecto-nucleotidase (cluster of differentiation 73...
• anti-CD73 monoclonal antibody JAB-BX102A humanized monoclonal antibody targeting the ectoenzyme 5'-ecto-nucleotidase (cluster of differentiation 73...
• anti-CD73 monoclonal antibody NZV930A fully human monoclonal antibody targeting the ectoenzyme 5'-ecto-nucleotidase (cluster of differentiation...
• anti-CD73 monoclonal antibody PT199A humanized monoclonal antibody directed against the human ectoenzyme 5'-ecto-nucleotidase (cluster of...
• anti-CD73 monoclonal antibody Sym024A monoclonal antibody targeting the ectoenzyme 5'-ecto-nucleotidase (cluster of differentiation 73; CD73...
• anti-CD79b antibody-drug conjugate SHR-A1912An antibody-drug conjugate (ADC) composed of a monoclonal antibody against the tumor-associated antigen (TAA)...
• anti-CD79b CAR T cellsA preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor...
• anti-CD79b/CD20/CD3 trispecific antibody JNJ-80948543A fully human effector-silent Fc immunoglobulin G1 (IgG1) trispecific antibody targeting the tumor-associated...
• anti-CD8b antibody/IL-2 mutein fusion protein AB248A recombinant fusion protein comprised of a humanized immunoglobulin G1 (IgG1) antibody targeting the T-cell...
• anti-CD93 monoclonal antibody DCBY02A monoclonal antibody directed against a specific epitope of the insulin-like growth factor-binding protein 7...
• anti-CD93 monoclonal antibody DCSZ11A monoclonal antibody directed against a specific epitope of the insulin-like growth factor-binding protein 7...
• anti-CD98 monoclonal antibody IGN523A humanized, monoclonal antibody targeting the CD98 (gp125) antigen, with potential immunomodulatory and...
• anti-CDH17/anti-CD3 bispecific antibody ARB202A bispecific antibody directed against both the T-cell surface antigen CD3 and the tumor-associated antigen...
• anti-CDH3/MMAE antibody-drug conjugate BC3195An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against the human...
• anti-CDH3/MSLN BiTE antibody AMG 305A dual-targeting bispecific antibody and T-cell engager (BiTE) co-targeting both the human tumor-associated...
• anti-CDH6 antibody-drug conjugate HKT288An immunoconjugate consisting of a human monoclonal antibody directed against the tumor-associated antigen...
• anti-CDH6/exatecan ADC CUSP06An antibody-drug conjugate (ADC) composed of a humanized monoclonal antibody directed against the...
• anti-CEA antibodyAn antibody against carcinoembryonic antigen (CEA), a protein present on certain types of cancer cells.
• anti-CEA BiTE monoclonal antibody AMG211A recombinant, proprietary bispecific T-cell engagers (BiTE) antibody directed against human carcinoembryonic...
• anti-CEA CAR T cellsA preparation of T lymphocytes engineered to express a chimeric antigen receptor (CAR) specific for the...
• anti-CEA IgCD28TCR-transduced autologous T cellsA population of autologous tumor infiltrating lymphocytes (TIL) transduced with a retroviral vector encoding...
• anti-CEA TCR retroviral vector-transduced autologous peripheral blood lymphocytesAutologous human peripheral blood lymphocytes (PBLs), transduced with a retroviral vector encoding both the...
• anti-CEA/anti-4-1BB bispecific antibodyA bispecific antibody targeting both carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5; CEA)...
• anti-CEA/Anti-4-1BB bispecific antibody BGB-B167A bispecific antibody targeting both the tumor-associated antigen (TAA) carcinoembryonic antigen-related cell...
• anti-CEA/anti-4-1BB bispecific antibody LM-24C5A bispecific antibody targeting both the tumor-associated antigen (TAA) carcinoembryonic antigen-related cell...
• anti-CEA/anti-CD3 bispecific antibody BA1202A bispecific antibody targeting both the tumor-associated antigen (TAA) carcinoembryonic antigen-related cell...
• anti-CEA/anti-CEACAM6 antibody-drug conjugate EBC-129An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against the tumor-associated...
• anti-CEA/anti-DR5 bispecific antibody IBI3004A bispecific antibody targeting both the tumor-associated antigen (TAA) carcinoembryonic antigen-related cell...
• anti-CEA/anti-DTPA-In (F6-734) bispecific antibodyA bispecific monoclonal antibody (BsMAb) consisting of the Fab fragment of an anti-CEA monoclonal antibody...
• anti-CEA/anti-HSG bispecific monoclonal antibody TF2A tri-Fab bispecific monoclonal antibody (BiMoAb) divalent for the carcinoembryonic antigen (CEA) and...
• anti-CEACAM1 monoclonal antibody CM-24A humanized monoclonal immunoglobulin G4 (IgG4) antibody targeting the anti-carcinoembryonic antigen...
• anti-CEACAM5 ADC SGN-CEACAM5CAn antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against the tumor-associated...
• anti-CEACAM5 antibody-drug conjugate BG-C477An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against the tumor-associated...
• anti-CEACAM5 antibody-drug conjugate M9140An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against the tumor-associated...
• anti-CEACAM6 AFAIKL2 antibody fragment/Jack Bean urease immunoconjugate L-DOS47A lyophilized formulation of DOS47, an immunoconjugate composed of AFAIKL2, a recombinant camelid...
• anti-CEA-CAR autologous T lymphocytesAutologous lymphocytes transduced with a retroviral vector encoding a chimeric antigen receptor (CAR)...
• anti-CFH monoclonal antibody GT103A recombinant human-derived monoclonal antibody targeting the tumor cell-protective protein complement factor...
• Anti-c-fms monoclonal antibody AMG 820A fully human IgG2 monoclonal antibody against the colony-stimulating factor-1 (CSF-1 or M-CSF) receptor...
• Anticipatory nausea and vomitingNausea and vomiting that may occur before a chemotherapy treatment session begins in a patient who has had...
• Anti-c-KIT Monoclonal Antibody CDX 0158A humanized immunoglobulin (Ig) G1 monoclonal antibody against the stem cell factor receptor c-Kit (SCFR...
• anti-c-Kit/MMAE antibody-drug conjugate NN3201An antibody-drug conjugate (ADC) composed of 2G4, a human monoclonal antibody directed against the stem cell...
• Anti-claudin 18.2 antibody-drug conjugate BL-M05D1An antibody-drug conjugate (ADC) composed of a wild-type Fc-containing immunoglobulin (IgG) monoclonal...
• Anti-claudin 18.2 antibody-drug conjugate CPO102An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against the tumor-associated...
• anti-Claudin 18.2 antibody-drug conjugate EO-3021An antibody-drug conjugate (ADC) composed of a human monoclonal antibody directed against the...
• anti-Claudin 18.2 antibody-drug conjugate JS107An antibody-drug conjugate (ADC) composed of a humanized monoclonal antibody directed against the...
• Anti-claudin 18.2 antibody-drug conjugate LM-302An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against the tumor-associated...
• Anti-claudin 18.2 antibody-drug conjugate SKB315An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against the tumor-associated...
• anti-Claudin 18.2 antibody-drug conjugate SOT102An antibody-drug conjugate (ADC) composed of an immunoglobulin G1 (IgG1) monoclonal antibody directed against...
• anti-Claudin 18.2 monoclonal antibody M108A monoclonal antibody directed against the tumor-associated antigen (TAA) Claudin18.2 (CLDN18.2; A2 isoform...
• Anti-claudin 18.2 monoclonal antibody MIL93A recombinant humanized immunoglobulin G1 (IgG1) monoclonal antibody directed against the tumor-associated...
• anti-claudin-1 monoclonal antibody ALE.C04A humanized monoclonal antibody directed against the tumor-associated antigen (TAA) claudin-1 (CLDN1...
• anti-Claudin18.2 ADC AZD0901An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against the tumor-associated...
• anti-Claudin18.2 antibody-drug conjugate IBI343An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against the tumor-associated...
• anti-Claudin18.2 CAR T cells IBI345A preparation of T lymphocytes engineered to express a chimeric antigen receptor (CAR) specific for the...
• anti-Claudin18.2 CAR T cells IM92A preparation of T lymphocytes engineered to express a chimeric antigen receptor (CAR) specific for the...
• anti-Claudin18.2 CAR T cells LCAR-C18SA preparation of T lymphocytes engineered to express a chimeric antigen receptor (CAR) specific for the...
• anti-claudin18.2 monoclonal antibody AB011A recombinant humanized monoclonal antibody directed against the tumor-associated antigen (TAA) Claudin18.2...
• anti-claudin18.2 monoclonal antibody ASKB589A monoclonal antibody directed against the tumor-associated antigen (TAA) Claudin18.2 (CLDN18.2; A2 isoform...
• anti-claudin18.2 monoclonal antibody LM-102A recombinant humanized monoclonal antibody directed against the tumor-associated antigen (TAA) claudin18.2...
• anti-Claudin-18.2 monoclonal antibody NBL-015A human monoclonal antibody directed against the tumor-associated antigen (TAA) Claudin18.2 (CLDN18.2; A2...
• anti-Claudin-18.2 monoclonal antibody SPX-101A humanized monoclonal antibody directed against the tumor-associated antigen (TAA) Claudin18.2 (CLDN18.2; A2...
• anti-Claudin18.2 monoclonal antibody TORL-2-307-MABA monoclonal antibody directed against the tumor-associated antigen (TAA) Claudin18.2 (CLDN18.2; A2 isoform...
• anti-claudin18.2/anti-4-1BB bispecific antibody TJ-CD4BA bispecific antibody composed of a human, Fc-silenced immunoglobulin G1 (IgG1) monoclonal antibody targeting...
• anti-claudin18.2/anti-CD3 bispecific antibody AZD5863An affinity-optimized T-cell engaging (TCE) and human bispecific antibody directed against the...
• anti-Claudin18.2/anti-CD3 bispecific antibody QLS31905A bispecific antibody directed against the tumor-associated antigen (TAA) Claudin18.2 (CLDN18.2; A2 isoform...
• anti-claudin18.2/anti-CD47 bispecific antibody PT886A bispecific antibody directed against both the tumor-associated antigen (TAA) Claudin18.2 (CLDN18.2; A2...
• anti-Claudin18.2/MMAE antibody-drug conjugate TORL-2-307-ADCAn antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against the tumor-associated...
• anti-CLDN18.2 antibody-drug conjugate TQB2103An antibody-drug conjugate (ADC) composed of a humanized monoclonal antibody directed against the...
• anti-CLDN18.2 CAR T cells LY011A preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor...
• anti-CLDN18.2 CAR-T cells AZD6422A preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor...
• anti-CLDN18.2 heavy chain antibody Fc fusion protein DR30303A fusion protein composed of a recombinant humanized anti-Claudin18.2 (CLDN18.2; A2 isoform of claudin-18)...
• anti-CLDN18.2 monoclonal antibody ZL-1211An engineered monoclonal antibody directed against the tumor-associated antigen (TAA) Claudin18.2 (CLDN18.2...
• anti-CLDN18.2/anti-4-1BB bispecific antibody PM1032A bispecific antibody directed against the tumor-associated antigen (TAA) Claudin18.2 (CLDN18.2; A2 isoform...
• anti-CLDN18.2/anti-CD3 bispecific antibody ASP2138A bispecific antibody directed against the tumor-associated antigen (TAA) Claudin18.2 (CLDN18.2; A2 isoform...
• anti-CLDN18.2/anti-PD-L1 CAR-T cellsA preparation of T lymphocytes that have been genetically modified to express chimeric antigen receptors...
• anti-CLDN18.2/CD47 bispecific antibody AK132A bispecific antibody directed against both the tumor-associated antigen (TAA) Claudin18.2 (CLDN18.2; A2...
• anti-CLDN18.2/CD47 bispecific antibody SG1906A recombinant, immunoglobulin G1 (IgG1) bispecific antibody directed against both the tumor-associated...
• anti-CLDN4/anti-CD137 bispecific antibody ASP1002A bispecific antibody directed against both claudin-4 (CLDN4) and CD137 (4-1BB; tumor necrosis factor...
• anti-CLDN6 antibody-drug conjugate DS-9606aAn antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against the tumor-associated...
• anti-CLDN6 CAR T cellsA preparation of T lymphocytes expressing a chimeric antigen receptor (CAR) targeting the cell surface...
• anti-CLDN6 monoclonal antibody ASP1650A monoclonal antibody directed against the cell surface protein claudin 6 (CLDN6), with potential...
• anti-CLDN6/9 antibody-drug conjugate SC-004An antibody-drug conjugate (ADC) composed of a proprietary monoclonal antibody directed against claudin-6...
• anti-CLDN6/CD3 bispecific antibody CTIM-76An Fc-silenced humanized immunoglobulin G1 (IgG1) bispecific antibody targeting both the tumor-associated...
• anti-CLDN6/CD3 bispecific antibody SAIL66A bispecific antibody targeting both the tumor-associated antigen (TAA) Claudin 6 (CLDN6; CLDN-6) and the...
• anti-CLDN6/CD3 bispecific antibody XmAb541A bispecific antibody directed against both the tumor-associated antigen (TAA) claudin 6 (CLDN6; CLDN-6) and...
• anti-CLDN6/CD3 BiTE antibody AMG 794A half-life extended (HLE) human bispecific T-cell engager (BiTE) antibody targeting the CD3 antigen...
• anti-CLEC12A/CD3 bispecific antibody MCLA117An immunoglobulin G1 (IgG1) bispecific human monoclonal antibody against human CD3, a T-cell surface antigen...
• anti-CLL1/anti-CD33 CAR-T cells LCAR-AMDRA preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor...
• anti-CLL-1/anti-CD38 CAR T cellsA preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor...
• anti-CLL1-PBD ADC DCLL9718SAn antibody-drug conjugate (ADC) consisting of MCLL0517A , an anti-C-type lectin-like molecule-1 (CLL-1...
• anti-c-Met antibody-drug conjugate BYON3521An antibody-drug conjugate (ADC) composed of a humanized immunoglobulin G1 (IgG1) monoclonal antibody against...
• anti-c-Met antibody-drug conjugate SHR-A1403An antibody-drug conjugate (ADC) composed of a monoclonal antibody against the tumor-associated antigen (TAA)...
• anti-c-Met antibody-drug conjugate TR1801An antibody-drug conjugate (ADC) consisting of a non-agonizing anti-c-Met humanized monoclonal antibody that...
• anti-c-Met antibody-drug conjugate YL211An antibody-drug conjugate (ADC) composed of a humanized monoclonal antibody directed against the...
• anti-c-Met monoclonal antibody ARGX-111A human monoclonal antibody targeting c-Met, with potential antineoplastic activity. Anti-c-Met monoclonal...
• anti-c-MET monoclonal antibody HLX55A humanized immunoglobulin (Ig) G2 monoclonal antibody directed against the human hepatocyte growth factor...
• anti-c-MET monoclonal antibody LY2875358A humanized IgG4 monoclonal antibody directed against human hepatocyte growth factor receptor (HGFR or c-MET)...
• anti-C-met monoclonal antibody SAIT301A humanized monoclonal antibody targeting the alpha chain of the extracellular domain of human hepatocyte...
• anti-c-Met/anti-TROP2/anti-CD3/anti-CD28 tetra-specific antibody MDX2001A tetra-specific antibody targeting the tumor-associated antigens (TAAs) proto-oncogene c-Met (hepatocyte...
• anti-cMET/EGFR/VEGF trispecific antibody TAVO412A trispecific antibody targeting hepatocyte growth factor receptor (HGFR; c-Met), epidermal growth factor...
• anti-c-Met/MMAE ADC MYTX-011An antibody-drug conjugate (ADC) composed of an engineered pH-dependent humanized immunoglobulin G1 (IgG1)...
• anti-c-Met/MMAE ADC RC108An antibody-drug conjugate (ADC) consisting of an anti-c-Met monoclonal antibody that is conjugated to...
• anti-CNTN4 antibody GENA-104A16An affinity-matured humanized monoclonal antibody directed against the inhibitory immune checkpoint protein...
• AnticoagulantA substance that is used to prevent and treat blood clots in blood vessels and the heart. Also called blood...
• AnticonvulsantA type of drug that is used to prevent or treat seizures or convulsions by controlling abnormal electrical...
• Anti-CSF1 monoclonal antibody PD-0360324A humanized immunoglobulin (Ig) G2 monoclonal antibody (mAb) directed against the cytokine colony stimulating...
• anti-CSF1R monoclonal antibody AMB-05XA human immunoglobulin G2 (IgG2) monoclonal antibody directed against the tyrosine kinase receptor colony...
• anti-CSF-1R monoclonal antibody IMC-CS4A monoclonal antibody directed against colony stimulating factor 1 receptor (CSF1R) with potential...
• anti-CSF1R monoclonal antibody IMC-CS4A monoclonal antibody directed against colony stimulating factor 1 receptor (CSF1R) with potential...
• anti-CTLA4 antibody Fc fusion protein KN044A recombinant, humanized fusion protein consisting of a cytotoxic T-lymphocyte-associated antigen 4 (CTLA4...
• anti-CTLA4 mAb RNA/GITRL RNA-transfected autologous dendritic cell vaccineAn autologous dendritic cell (DC) cancer vaccine with potential immunostimulatory activity. Anti-CTLA4 MoAb...

3,095 of 17,717 terms in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.